Oral delivery remains a major goal for peptide drug development, despite the challenges posed by gastrointestinal degradation and poor absorption
WIRES Nanomed Nanobi 9 (2), e1410
In rats, central administration of MT-2 suppressed food intake by approximately 30% in a dose-dependent manner
Managing Expectations & Practical Guidance for Patients As orforglipron moves toward approval and commercial availability, patients, providers, and the broader public will need realistic expectations about what this drug can and cannot do
Its Science Inspired by your body's own processes, our once-weekly weight loss meds mimic natural hormones to control appetite effectively
In a report released in October, the CBO warned that subsidizing GLP-1 drugs could have unpredictable costs due to several key uncertainties